Sentinel node staging for cutaneous melanoma in a university-affiliated community care setting

Annals of Surgical Oncology

Volumn 7, Issue 6, 2000, Pages 450-455

  Wong, Jan H ^a   Steinemann, Susan ^a   Yonehara, Cyndee ^a   Coel, Marc N ^b   Ko, Peter J ^b   Tonaki, Keith ^b   Tauchi, Pamela ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b QUEEN S MEDICAL CENTER   (United States)

Author keywords

Cutaneous lymphoscintigraphy; Cutaneous melanoma; Sentinel lymphadenectomy

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA;

EID: 0033932149     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0450-x     Document Type: Article

References (31)

1. Balch CM, Murad TM, Soong SJ, et al. Tumour thickness as a guide to surgical management of clinical stage I melanoma. Cancer 1979;43:883-8.
2. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Ann Surg 1991;214:491-501.
3. Sim HI, Taylor WF, Ivins JC, et al. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer 1978;41:948-56.
4. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-30.
5. Balch CM, Soon SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanoma for patients 60 years of age and younger. Ann Surg 1996;224:255-66.
6. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
7. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
8. Krag DN, Meijer SJ, Weaver DL, et al. Minimal access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
9. Leong SPL, Steinmetz I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997;132:666-73.
10. Ross MI, Reintgen D, Balch C. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 1993;9:219-23.
11. Thompson J, McCarthy W, Robinson E. Sentinel lymph node biopsy in 102 patients with clinical stage I melanoma undergoing elective lymph node dissection. Presented at the 47th Cancer Symposium of the Society of Surgical Oncology, Houston, TX, March 1994.
12. Emilia JCD, Lawrence W Jr. Sentinel lymph node biopsy in malignant melanoma: the standard of care? J Surg Oncol 1997;65: 153-4.
13. Cascinelli N. An overview on sentinel lymph node dissection. Presented at the 9th International Congress on Anti-Cancer Treatments, Paris, France, 1999.
14. Morton DL. Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard or clinical investigation? Cancer J 1997;3:328-30.
15. Alex J, Krag D. Gamina-probe-guided localization of lymph nodes. Surg Oncol 1993;2:137-44.
16. Albertini JJ, Cruse WC, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification in melanoma. Ann Surg 1996;223:217-24.
17. Robinson DS, Sample WF, Fee HJ, Holmes EC, Morton DL. Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning. Surg Forum 1972;28:147-8.
18. Norman J, Cruse CW, Espinosa C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg 1991;162:432-7.
19. Reintgen D, Albertini J, Berman C, et al. Accurate nodal staging of malignant melanoma. Cancer Control 1995;405-14.
20. McMasters KM, Giuliano AE, Ross MI, et al. Sentinel lymph node biopsy for breast cancer: not yet the standard of care. N Engl J Med 1998;339:990-5.
21. Morton DL. Introduction: sentinel lymphadenectomy for patients with clinical stage I melanoma. J Surg Oncol 1997;66:267-9.
22. Thompson JF. Sentinel node biopsy. J Surg Oncol 1997;66:270-2.
23. Ross MI. Lymphatic mapping and sentinel node biopsy for early stage melanoma: how we do it at the M. D. Anderson Cancer Center. J Surg Oncol 1997;66:273-6.
24. Reintgen D. Lymphatic mapping and sentinel node harvest for malignant melanoma. J Surg Oncol 1997;66:277-81.
25. Karakousis CP, Najibi S, Trunk J. Sentinel node biopsy in malignant melanoma. J Surg Oncol 1997;66:282-4.
26. O'brien CJ, Uren RF, Thompson JF, et al. Prediction of potential metastatic sites in cutaneous head and neck melanoma using lymphoscintigraphy. Am J Surg 1995;170:461-6.
27. Essner R, Foshag LJ, Morton DL. Intraoperative radiolymphoscintigraphy: a useful adjunct to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma. Presented at the 47th Annual Meeting of the Society of Surgical Oncology, Houston, TX, March 1994.
28. Wells KE, Rapaport DP, Cruse CW, et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plant Reconstr Surg 1997;100:591-4.
29. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J 1997;3:336-40.
30. Wanebo HJ, Harpole D, Teates CD. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk. Cancer 1985;55:1403-13.
31. Norman JG, Cruse CW, Ruas E, et al. The expanding role of lymphoscintigraphy in the management of cutaneous melanoma. Am Surg 1989;12:689-94.